The Biden Administration Requests’reasonable’ Rates For Upgraded Covid Vaccinations From Pfizer, Moderna, And Novavax
The Biden administration encouraged Pfizer, Moderna, and Novavax on Thursday to charge “reasonable” prices for their improved covid vaccinations when they launch them in the United States this autumn. The U.S. Department of Health and Human Services warned the makers in a letter that overcharging for the additional shots would violate “the trust the American people have placed in you through the COVID-19 response.” The future single-strain Covid vaccinations that the three firms are developing to combat the prevalent omicron subvariant XBB.1.5 are not yet priced precisely. Earlier this year, Pfizer and Moderna stated they anticipated pricing their shots between $110 and $130 each dose, a nearly fivefold increase over the costs of the already available vaccines. Legislators have criticized the estimate, pointing out that the two businesses and their CEOs generated large profits from the shots during the Covid-19 outbreak. As the federal government is anticipated to switch the dis...